CORCEPT THERAPEUTICS INC Total Liabilities
CORCEPT THERAPEUTICS INC (CORT) had Total Liabilities of $182.93 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-07-29
- 2026-06-30: Liabilities $182.93M.
- 2026-03-31: Liabilities $176.89M.
- 2025-12-31: Liabilities $188.85M.
- 2025-09-30: Liabilities $191.71M.
| Period end | Liabilities |
|---|---|
| 2026-06-30 | $182.93M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $176.89M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $188.85M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $191.71M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $165.93M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $163.17M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $160.96M 10-K · filed 2026-02-24 |
| 2024-09-30 | $145.42M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $118.31M 10-Q · filed 2024-07-29 |
| 2024-03-31 | $108.07M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $114.81M 10-K · filed 2025-02-26 |
| 2023-09-30 | $132.34M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $103.01M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $88.26M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $81.59M 10-K · filed 2024-02-15 |
| 2022-09-30 | $59.89M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $54.04M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $60.31M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $47.95M 10-K · filed 2023-02-28 |
| 2021-09-30 | $45.17M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $45.80M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $41.60M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $48.39M 10-K · filed 2022-02-15 |
| 2020-09-30 | $44.45M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $44.13M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $36.01M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $41.13M 10-K · filed 2021-02-23 |
| 2019-09-30 | $32.65M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $30.63M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $34.46M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $35.81M 10-K · filed 2020-02-24 |
| 2017-12-31 | $29.57M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |